ITM2B and ABri amyloidosis: We observed evidence for neither reduced ITM2B/BRI2 protein abundance in our FBD patient-derived microglial model nor altered inflammatory profiles of FBD microglia under basal conditions—supporting the first hypothesis or a combination of both.